We use some essential cookies to make this website work.
We’d like to set additional cookies to understand how you use GOV.UK, remember your settings and improve government services.
We also use cookies set by other sites to help us deliver content from their services.
You have accepted additional cookies. You can change your cookie settings at any time.
You have rejected additional cookies. You can change your cookie settings at any time.
Departments, agencies and public bodies
News stories, speeches, letters and notices
Detailed guidance, regulations and rules
Reports, analysis and official statistics
Consultations and strategy
Data, Freedom of Information releases and corporate reports
A summary of what delivering better integrated care means and how Monitor is supporting the sector.
This guidance outlines how to make informed choices about your organisation’s reliance on cloud technologies.
Get help to classify pharmaceutical products used to treat or prevent diseases or ailments (in humans or animals), including comparators used in clinical trials and placebos.
This guidance provides information on comparator products used in studies supporting abridged marketing authorisation applications
A register of agreements relating to exclusion orders made by powers under paragraph 7 of Schedule 3 to The Competition Act 1998.
There are changes to the legislation of Reference Medicinal Products (RMPs) used to support abridged marketing authorisation applications
There are different regulations which apply to devices and equipment including hand gels and PPE (personal protective equipment)
The Medicines and Healthcare products Regulatory Agency regulates medicines, medical devices and blood components for transfusion in the UK. MHRA is an executive agency, sponsored by the Department of Health and Social Care .
What you need to know before you can place a medical device on the Great Britain market with a UKCA mark.
Guidance for the pharmaceutical industry on Marketing Authorisations for veterinary medicines.
Resources to help anyone developing or running a digital health product to conduct an evaluation.
The way you apply to licence biological products has changed
The MHRA has authorised cabotegravir as 30 mg tablets and as a 600 mg long-acting injection administered every two months
How to submit your periodic safety update report report (PSUR) or periodic benefit risk evaluation report (PBRER)
Information about the EU Regulations and their implementation in Northern Ireland
Information and guidance on a range of medical devices for users and patients.
Provider guidance is for organisations contracted to deliver provision for DWP.
Information on how to request assistance from NSDR.
How to register your medical devices with the Medicines and Healthcare products Regulatory Agency (MHRA) for the markets in Great Britain and Northern Ireland
PRaP allows DWP and Welfare to Work providers to exchange information and payments securely.
Don’t include personal or financial information like your National Insurance number or credit card details.
To help us improve GOV.UK, we’d like to know more about your visit today. We’ll send you a link to a feedback form. It will take only 2 minutes to fill in. Don’t worry we won’t send you spam or share your email address with anyone.